GRM2 and schizophrenia: Interactions between mGlu2/3 and monoamines, particularly dopamine, are of interest because of the putative roles of these receptors in the pathophysiology and therapy of various dopamine-related psychiatric disorders, including schizophrenia, anxiety, and addiction.